CellCept® Dose Adjustment Versus Fixed Dose (Standard Care) in Renal Transplant Recipients (MMF)

Share this content:
CellCept® Dose Adjustment Versus Fixed Dose (Standard Care) in Renal Transplant Recipients (MMF)

Sponsor and Collaborators
Rabin Medical Center

Contact
Eytan Mor, Prof.
+972-39376452

Alexander Yussim, Dr.
+972-39376528

Principal Investigator
Eytan Mor, Prof.
Rabin Medical Center

Richard Nakache, Prof.
Sorasky Medical Center

ClinicalTrials.gov Identifier
NCT00737659
You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters